66 related articles for article (PubMed ID: 23615713)
21. Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer.
Xue B; Wu W; Huang K; Xie T; Xu X; Zhang H; Qi C; Ge J; Yu Y
Mol Cell Biochem; 2013 Aug; 380(1-2):177-84. PubMed ID: 23615713
[TBL] [Abstract][Full Text] [Related]
22. Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells.
Huang WS; Chin CC; Chen CN; Kuo YH; Chen TC; Yu HR; Tung SY; Shen CH; Hsieh YY; Guo SE; Shi CS; Liu TJ; Kuo HC
J Cell Physiol; 2012 Mar; 227(3):1114-22. PubMed ID: 21567400
[TBL] [Abstract][Full Text] [Related]
23. SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6.
Wang B; Wang W; Niu W; Liu E; Liu X; Wang J; Peng C; Liu S; Xu L; Wang L; Niu J
Carcinogenesis; 2014 Feb; 35(2):282-91. PubMed ID: 24085800
[TBL] [Abstract][Full Text] [Related]
24. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
Whitley BR; Beaulieu LM; Carter JC; Church FC
Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
[TBL] [Abstract][Full Text] [Related]
25. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.
Ahmed N; Pansino F; Baker M; Rice G; Quinn M
J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393
[TBL] [Abstract][Full Text] [Related]
26. Stromal cell-derived factor-1/CXCR4 promotes IL-6 production in human synovial fibroblasts.
Chen HT; Tsou HK; Hsu CJ; Tsai CH; Kao CH; Fong YC; Tang CH
J Cell Biochem; 2011 Apr; 112(4):1219-27. PubMed ID: 21312239
[TBL] [Abstract][Full Text] [Related]
27. A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo.
Eberlein C; Kendrew J; McDaid K; Alfred A; Kang JS; Jacobs VN; Ross SJ; Rooney C; Smith NR; Rinkenberger J; Cao A; Churchman A; Marshall JF; Weir HM; Bedian V; Blakey DC; Foltz IN; Barry ST
Oncogene; 2013 Sep; 32(37):4406-16. PubMed ID: 23108397
[TBL] [Abstract][Full Text] [Related]
28. TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression.
Hezel AF; Deshpande V; Zimmerman SM; Contino G; Alagesan B; O'Dell MR; Rivera LB; Harper J; Lonning S; Brekken RA; Bardeesy N
Cancer Res; 2012 Sep; 72(18):4840-5. PubMed ID: 22787119
[TBL] [Abstract][Full Text] [Related]
29. Role of integrins in regulating proteases to mediate extracellular matrix remodeling.
Yue J; Zhang K; Chen J
Cancer Microenviron; 2012 Dec; 5(3):275-83. PubMed ID: 22437309
[TBL] [Abstract][Full Text] [Related]
30. Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer.
Yang SB; Du Y; Wu BY; Xu SP; Wen JB; Zhu M; Cai CH; Yang PC
Cancer Immunol Immunother; 2012 Mar; 61(3):335-42. PubMed ID: 21913024
[TBL] [Abstract][Full Text] [Related]
31. CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.
Righi E; Kashiwagi S; Yuan J; Santosuosso M; Leblanc P; Ingraham R; Forbes B; Edelblute B; Collette B; Xing D; Kowalski M; Mingari MC; Vianello F; Birrer M; Orsulic S; Dranoff G; Poznansky MC
Cancer Res; 2011 Aug; 71(16):5522-5534. PubMed ID: 21742774
[TBL] [Abstract][Full Text] [Related]
32. CXCL12 (SDF-1)/CXCR4 pathway in cancer.
Teicher BA; Fricker SP
Clin Cancer Res; 2010 Jun; 16(11):2927-31. PubMed ID: 20484021
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinases: regulators of the tumor microenvironment.
Kessenbrock K; Plaks V; Werb Z
Cell; 2010 Apr; 141(1):52-67. PubMed ID: 20371345
[TBL] [Abstract][Full Text] [Related]
34. Defining the role of integrin alphavbeta6 in cancer.
Bandyopadhyay A; Raghavan S
Curr Drug Targets; 2009 Jul; 10(7):645-52. PubMed ID: 19601768
[TBL] [Abstract][Full Text] [Related]
35. Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche.
Gillette JM; Larochelle A; Dunbar CE; Lippincott-Schwartz J
Nat Cell Biol; 2009 Mar; 11(3):303-11. PubMed ID: 19198600
[TBL] [Abstract][Full Text] [Related]
36. Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q).
Xu MY; Porte J; Knox AJ; Weinreb PH; Maher TM; Violette SM; McAnulty RJ; Sheppard D; Jenkins G
Am J Pathol; 2009 Apr; 174(4):1264-79. PubMed ID: 19147812
[TBL] [Abstract][Full Text] [Related]
37. Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2.
Yuecheng Y; Xiaoyan X
Eur J Cancer Prev; 2007 Oct; 16(5):430-5. PubMed ID: 17923814
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
39. Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.
Sun YX; Fang M; Wang J; Cooper CR; Pienta KJ; Taichman RS
Prostate; 2007 Jan; 67(1):61-73. PubMed ID: 17034033
[TBL] [Abstract][Full Text] [Related]
40. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis.
Kryczek I; Wei S; Keller E; Liu R; Zou W
Am J Physiol Cell Physiol; 2007 Mar; 292(3):C987-95. PubMed ID: 16943240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
